The 2nd International Congress on Clinical Trials in Oncology an

ICTO2018 follows the success of the 1st inaugural Congress which took place March 2017 in London and will again bring together world renowned speakers in the field of Clinical Trials in Oncology and Hemato-Oncology. The Congress will welcome oncology professionals, treatment experts, CRO’s, industry leaders and other experts to the majestic city of Berlin.

ICTO2018 will provide an outstanding scientific, educational and networking experience.

The congress will focus on areas including:

Design of clinical trials in the new era Personalized cancer medicine
Immuno-oncology
Monitoring of Trials and Statistics
Regulations – Survival based Medicine
Phase 4 Trials
Expanded access trials
Ethics and Patients’ Rights
Healthcare economy
Our goal is for ICTO2018 to be the forerunner in analysis, interpretation and translation of data and knowledge relating to Clinical Trials in Oncology and Hemato-Oncology.